PTPRC and neoplasm: Moreover, treatment with SGLT2 inhibitor or 2’3’-cGAMP alone or in combination promoted tumor infiltration by CD45+CD4+ and CD45+CD8+ T cells (Fig. 6h and Supplementary Fig. 4c), which may explain their synergistic effect in suppressing tumor growth.